Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01852968 · ClinicalTrials.gov registry record

Hippocampal Metabolism and Function in Patients With Type 1 Diabetes

A clinical trial of Diabetes Mellitus and Hypoglycemia, sponsored by University of Minnesota.

Completed
Registry status
57
Enrollment target
1
Study location

NCT01852968 is a study of Diabetes Mellitus and Hypoglycemia that has completed, run by University of Minnesota. The registered enrollment target is 57 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01852968, a study of Diabetes Mellitus and Hypoglycemia, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
57 participants
Enrollment target
1
Study location

Study Summary

The hippocampus is an area of brain which plays an essential role in learning and memory processing and is thought to be particularly vulnerable to effects of hypoglycemia (low blood glucose). The goal of this project is to examine hippocampal neurochemistry and metabolism and identify how diabetes and recurrent hypoglycemia alter the hippocampus.

Study Locations (1)

Minnesota

  • Clinical and Translational Science Institute and Center for Magnetic Resonance Research, University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 57 participants
Start Date 2013-05
Est. Completion 2017-10-31

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT01852968

The ClinicalTrials.gov registry entry for NCT01852968 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (97% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 0 interventions.

NCT01852968 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT01852968 about?

NCT01852968 is a clinical study titled "Hippocampal Metabolism and Function in Patients With Type 1 Diabetes". The hippocampus is an area of brain which plays an essential role in learning and memory processing and is thought to be particularly vulnerable to effects of hypoglycemia (low blood glucose). The goal of this project is to examine hippocampal neurochemistry and metabolism and identify how diabetes ...

What is the current status of trial NCT01852968?

This trial is currently completed. The enrollment target is 57 participants. The study started on 2013-05. Estimated completion is 2017-10-31.

What conditions does trial NCT01852968 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Hypoglycemia.

Who is sponsoring clinical trial NCT01852968?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01852968 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.